# Pneumococcal Vaccines Early and in Combination

> **NCT01174849** · PHASE4 · COMPLETED · sponsor: **Menzies School of Health Research** · enrollment: 425 (actual)

## Conditions studied

- Otitis Media

## Interventions

- **DRUG:** Synflorix
- **DRUG:** Prevenar13
- **DRUG:** COMBO

## Key facts

- **NCT ID:** NCT01174849
- **Lead sponsor:** Menzies School of Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2017-09-21
- **Final completion:** 2018-03-15
- **Target enrollment:** 425 (ACTUAL)
- **Last updated:** 2018-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01174849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01174849, "Pneumococcal Vaccines Early and in Combination". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01174849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*